Systematic review of 36 US oncology studies (two domains meta-analysed): 30 reported financial conflicts of interest prevalence above 50%. Pooled prevalence was 69% for industry sponsorship of cancer trials and 61% for industry general payments to practising oncologists.
Meta-analysisn = 36 articles
Kim et al. Prevalence of industry ties in the US cancer ecosystem: a systematic review and meta-analysis